Matches in SemOpenAlex for { <https://semopenalex.org/work/W2044177786> ?p ?o ?g. }
Showing items 1 to 98 of
98
with 100 items per page.
- W2044177786 endingPage "300" @default.
- W2044177786 startingPage "296" @default.
- W2044177786 abstract "Background: Endpoints used to evaluate the efficacy of acute anti-migraine drugs do not measure the tolerability. Sustained pain-free response with no adverse events has been recommended as a composite endpoint which measures the efficacy and tolerability attributes that patients desire. Methods: The aim of this study was to evaluate new composite efficacy-plus-tolerability endpoints based on a post-hoc analysis of patient-level data from a previous randomized, placebo-controlled trial of the calcitonin gene-related peptide (CGRP) receptor antagonist, telcagepant, and zolmitriptan in the acute treatment of migraine. Endpoints were 2–24-hour sustained pain freedom and no adverse events from 0–24 hours (SPF24NAE), 2–24 hour sustained pain relief and no adverse events from 0–24 hours (SPR24NAE), pain freedom at 2 hours and no adverse events from 0–24 hours (PF2NAE), and pain relief at 2 hours and no adverse events from 0–24 hours (PR2NAE). Results: Compared with placebo, both telcagepant 300 mg and 150 mg achieved nominal superiority ( p values <.05) for SPF24NAE, SPR24NAE, PF2NAE and PR2NAE. Zolmitriptan 5 mg showed nominal superiority versus placebo for SPF24NAE, SPR24NAE and PF2NAE, but not PR2NAE. Telcagepant 300 mg showed nominal superiority versus zolmitriptan for SPF24NAE, SPR24NA and PR2NAE. Conclusion: Composite efficacy-plus-tolerability endpoints may be useful for facilitating comparisons between treatments." @default.
- W2044177786 created "2016-06-24" @default.
- W2044177786 creator A5021135644 @default.
- W2044177786 creator A5038612684 @default.
- W2044177786 creator A5050461006 @default.
- W2044177786 creator A5057290642 @default.
- W2044177786 creator A5074447840 @default.
- W2044177786 date "2010-10-11" @default.
- W2044177786 modified "2023-09-25" @default.
- W2044177786 title "Sustained pain freedom and no adverse events as an endpoint in clinical trials of acute migraine treatments: Application to patient-level data from a trial of the CGRP receptor antagonist, telcagepant, and zolmitriptan" @default.
- W2044177786 cites W1966041812 @default.
- W2044177786 cites W1975132866 @default.
- W2044177786 cites W1990698167 @default.
- W2044177786 cites W2005128914 @default.
- W2044177786 cites W2007669780 @default.
- W2044177786 cites W2022575186 @default.
- W2044177786 cites W2047700866 @default.
- W2044177786 cites W2073074795 @default.
- W2044177786 cites W2079490818 @default.
- W2044177786 cites W2098988727 @default.
- W2044177786 cites W2114413295 @default.
- W2044177786 cites W2120959053 @default.
- W2044177786 cites W2123955989 @default.
- W2044177786 cites W2135858080 @default.
- W2044177786 cites W2149133494 @default.
- W2044177786 cites W2157484161 @default.
- W2044177786 cites W4230891577 @default.
- W2044177786 doi "https://doi.org/10.1177/0333102410385585" @default.
- W2044177786 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20937606" @default.
- W2044177786 hasPublicationYear "2010" @default.
- W2044177786 type Work @default.
- W2044177786 sameAs 2044177786 @default.
- W2044177786 citedByCount "14" @default.
- W2044177786 countsByYear W20441777862012 @default.
- W2044177786 countsByYear W20441777862013 @default.
- W2044177786 countsByYear W20441777862014 @default.
- W2044177786 countsByYear W20441777862015 @default.
- W2044177786 countsByYear W20441777862016 @default.
- W2044177786 countsByYear W20441777862020 @default.
- W2044177786 countsByYear W20441777862021 @default.
- W2044177786 crossrefType "journal-article" @default.
- W2044177786 hasAuthorship W2044177786A5021135644 @default.
- W2044177786 hasAuthorship W2044177786A5038612684 @default.
- W2044177786 hasAuthorship W2044177786A5050461006 @default.
- W2044177786 hasAuthorship W2044177786A5057290642 @default.
- W2044177786 hasAuthorship W2044177786A5074447840 @default.
- W2044177786 hasConcept C126322002 @default.
- W2044177786 hasConcept C142724271 @default.
- W2044177786 hasConcept C168563851 @default.
- W2044177786 hasConcept C170493617 @default.
- W2044177786 hasConcept C197934379 @default.
- W2044177786 hasConcept C203092338 @default.
- W2044177786 hasConcept C204787440 @default.
- W2044177786 hasConcept C27081682 @default.
- W2044177786 hasConcept C2778375690 @default.
- W2044177786 hasConcept C2778541695 @default.
- W2044177786 hasConcept C2778871607 @default.
- W2044177786 hasConcept C2778938600 @default.
- W2044177786 hasConcept C2779085531 @default.
- W2044177786 hasConcept C42219234 @default.
- W2044177786 hasConcept C71924100 @default.
- W2044177786 hasConceptScore W2044177786C126322002 @default.
- W2044177786 hasConceptScore W2044177786C142724271 @default.
- W2044177786 hasConceptScore W2044177786C168563851 @default.
- W2044177786 hasConceptScore W2044177786C170493617 @default.
- W2044177786 hasConceptScore W2044177786C197934379 @default.
- W2044177786 hasConceptScore W2044177786C203092338 @default.
- W2044177786 hasConceptScore W2044177786C204787440 @default.
- W2044177786 hasConceptScore W2044177786C27081682 @default.
- W2044177786 hasConceptScore W2044177786C2778375690 @default.
- W2044177786 hasConceptScore W2044177786C2778541695 @default.
- W2044177786 hasConceptScore W2044177786C2778871607 @default.
- W2044177786 hasConceptScore W2044177786C2778938600 @default.
- W2044177786 hasConceptScore W2044177786C2779085531 @default.
- W2044177786 hasConceptScore W2044177786C42219234 @default.
- W2044177786 hasConceptScore W2044177786C71924100 @default.
- W2044177786 hasIssue "3" @default.
- W2044177786 hasLocation W20441777861 @default.
- W2044177786 hasLocation W20441777862 @default.
- W2044177786 hasOpenAccess W2044177786 @default.
- W2044177786 hasPrimaryLocation W20441777861 @default.
- W2044177786 hasRelatedWork W1487552975 @default.
- W2044177786 hasRelatedWork W1550475500 @default.
- W2044177786 hasRelatedWork W2022556905 @default.
- W2044177786 hasRelatedWork W2039874384 @default.
- W2044177786 hasRelatedWork W2085350396 @default.
- W2044177786 hasRelatedWork W2088590171 @default.
- W2044177786 hasRelatedWork W2473050951 @default.
- W2044177786 hasRelatedWork W2899506043 @default.
- W2044177786 hasRelatedWork W2981358442 @default.
- W2044177786 hasRelatedWork W3212096909 @default.
- W2044177786 hasVolume "31" @default.
- W2044177786 isParatext "false" @default.
- W2044177786 isRetracted "false" @default.
- W2044177786 magId "2044177786" @default.
- W2044177786 workType "article" @default.